Sally Mossman

Title: The Innovative Contributions of Sally Mossman

Introduction

Sally Mossman is a notable inventor based in Seattle, WA (US). She has made significant contributions to the field of immunology through her innovative work in vaccine compositions. Her research focuses on enhancing immune responses, which is crucial for developing effective treatments for various diseases.

Latest Patents

Mossman holds a patent for "Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21." This invention provides pharmaceutical compositions, particularly vaccine compositions, that employ an adjuvant system comprising RC-529 (an aminoalkyl glucosaminide phosphate compound) and QS-21 (a saponin). These compositions synergistically enhance the immune response in mammals to co-administered antigens. Additionally, the patent outlines methods for using these compositions in treating various human diseases, including cancer, microbial infections, and autoimmune disorders. She has 1 patent to her name.

Career Highlights

Throughout her career, Sally Mossman has worked with prominent companies in the biotechnology sector. Notably, she has been associated with Corixa Corporation and Antigenics, Inc. Her work in these organizations has contributed to advancements in vaccine development and immunotherapy.

Collaborations

Mossman has collaborated with various professionals in her field, including her coworker Lawrence Evans. These collaborations have played a vital role in her research and the successful development of her patented inventions.

Conclusion

Sally Mossman's innovative contributions to immunology and vaccine development highlight her importance in the field. Her work continues to influence the treatment of various diseases, showcasing the impact of her inventions on public health.